See more : Marubeni Construction Material Lease Co.,Ltd. (9763.T) Income Statement Analysis – Financial Results
Complete financial analysis of Rock Creek Pharmaceuticals, Inc. (RCPIQ) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Rock Creek Pharmaceuticals, Inc., a leading company in the Biotechnology industry within the Healthcare sector.
- Barksdale Resources Corp. (2NZ.F) Income Statement Analysis – Financial Results
- HELLA GmbH & Co. KGaA (HLE.DE) Income Statement Analysis – Financial Results
- Sandu Pharmaceuticals Limited (SANDUPHQ.BO) Income Statement Analysis – Financial Results
- JCET Group Co., Ltd. (600584.SS) Income Statement Analysis – Financial Results
- Home Plate Acquisition Corp. (HPLT) Income Statement Analysis – Financial Results
Rock Creek Pharmaceuticals, Inc. (RCPIQ)
About Rock Creek Pharmaceuticals, Inc.
Rock Creek Pharmaceuticals, Inc., a pharmaceutical development company, focuses on the discovery, development, and commercialization of therapies for chronic inflammatory disease and neurologic disorders. Its lead compound is Anatabine citrate, a small molecule, cholinergic agonist, which exhibits anti-inflammatory pharmacological characteristics, with a mechanism of action distinct from other anti-inflammatory drugs available, such as biologics, steroids, and non-steroidal anti-inflammatories. The company was formerly known as Star Scientific, Inc. and changed its name to Rock Creek Pharmaceuticals, Inc. in June 2014. Rock Creek Pharmaceuticals, Inc. is headquartered in Sarasota, Florida. On September 27, 2016, Rock Creek Pharmaceuticals, Inc., along with its affiliates, filed a voluntary petition for liquidation under Chapter 7 in the US Bankruptcy Court for the District of Delaware.
Source: https://incomestatements.info
Category: Stock Reports